2004
DOI: 10.1111/j.1440-1746.2004.03420.x
|View full text |Cite
|
Sign up to set email alerts
|

Practical difficulties in the management of hepatitis B in the Asia–Pacific region

Abstract: The Asia-Pacific Expert Committee on Hepatitis B Management recently reviewed the impact of hepatitis B in the region and assessed the differences and similarities observed in the practical management of the disease in individual Asia-Pacific countries. Hepatitis B is a major health concern in the AsiaPacific region, and of all chronically infected carriers worldwide, approximately 75% are found in Asia. The disease poses a considerable burden on healthcare systems, and is likely to remain a cause of substanti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
69
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 57 publications
(73 citation statements)
references
References 32 publications
4
69
0
Order By: Relevance
“…In Israel, the percentage of nurses who shun contact (77.3 %) with HIV, HBV, and HCV infected patients is much higher (15), but this may mostly be related to the fear of HIV/AIDS (17). These results however confi rm that HCV patients are stigmatised (18)(19)(20)(21) and that this kind of intolerance leads adversely affects the quality of patient care (22).…”
Section: Knowledge About Hcv Infectionmentioning
confidence: 99%
“…In Israel, the percentage of nurses who shun contact (77.3 %) with HIV, HBV, and HCV infected patients is much higher (15), but this may mostly be related to the fear of HIV/AIDS (17). These results however confi rm that HCV patients are stigmatised (18)(19)(20)(21) and that this kind of intolerance leads adversely affects the quality of patient care (22).…”
Section: Knowledge About Hcv Infectionmentioning
confidence: 99%
“…Although HB is classified as "disease of priority," there is an incessant increase in detection of new cases worldwide [6]. Furthermore, HB is widespread in the Asia Pacific region and 10 to 15 million of the population suffer from this disease [7][8][9]. Similar to what is reported worldwide, the incidence of HB infection is on continuous rise in India [10].…”
mentioning
confidence: 86%
“…In contrast, patients who contracted the disease later in life are less likely to suffer serious sequelae (only~20% develop cirrhosis or HCC) since their disease has had a relatively shorter time to progress. Despite geographic differences in genotypes and in the prevalence of HBeAg-positive and -negative disease [16][17][18][19][20] (Table 1), clinicians worldwide are now more likely to encounter patients of all genotypes and both HBeAg-positive and -negative disease during their practice as a result of population migration, and consequently need to know how to treat all types of patient appropriately.…”
Section: Burden Of Diseasementioning
confidence: 99%
“…Rates of HBsAg loss have been reported in 5-10% of European patients during 1 year of treatment, increasing to 11-25% among sustained responders over a 5-year follow-up period [20,23,25,26]. Long-term follow-up of a group of HBeAg-positive patients who responded to IFN suggested that the remissions induced are of long duration and were followed in most cases by loss of HBsAg and lack of evidence of HBV replication [27].…”
Section: Conventional Interferonmentioning
confidence: 99%